Bessemer Survey of 400+ Buyers Maps Where Healthcare AI Budgets Are Actually Going

Peer data replaces guesswork in clinical AI budget planning

Bessemer Venture Partners published a Healthcare AI Adoption Index based on a survey of more than 400 healthcare buyers across providers and payers in the United States. The report segments AI adoption and spending across five categories: clinical decision support, imaging, documentation, revenue cycle, and patient engagement. For enterprise buyers, this is the first large-scale quantitative snapshot of where AI dollars are flowing in healthcare—comparable in function to Gartner's Hype Cycle or KLAS benchmarks, but focused on vendor opportunity and buyer priorities.

The immediate impact: CIOs and CFOs now have a peer baseline to justify or kill clinical AI projects. If a proposed AI initiative does not appear among high-adoption categories in a 400-buyer sample, boards and risk committees will treat it as a red flag. Vendors will align roadmaps and sales messaging to the categories that index as high adoption and near-term ROI, which means buyers should expect heavier competition and more aggressive pricing in those segments.

Vertical LLMs for clinicians and patients hit evaluation phase at scale

A set of health-specific large language models launched earlier in 2026 are now being treated by providers as standard options for 2027 planning cycles rather than experimental pilots. OpenAI released ChatGPT Health for patients and ChatGPT for Clinicians for physicians and pharmacists in the United States. Anthropic launched Claude Health about two weeks after ChatGPT Health as a direct patient-facing competitor. Microsoft shipped Copilot Health in March 2026, integrating EHR data, medical databases, and wearables so clinicians receive patient context before a visit. In China, Ant Group's Ant Aofu healthcare LLM has reached 30 million patient users, combining health Q&A, appointment scheduling, and insurance payments via Alipay in a single interface.

ChatGPT for Clinicians is trained on medical databases and textbooks and handles literature summarization and clinical reasoning for physicians and pharmacists. ChatGPT Health targets patients with health-related questions and wearables data integration but is explicitly not approved for medical diagnosis. Claude Health offers similar patient-facing health information capabilities with Anthropic's safety-focused LLM tuning. Copilot Health is designed for enterprise deployment, integrating deeply with the Microsoft 365 stack and Azure-connected EHR systems.

Vertical healthcare LLMs are now table stakes in clinical RFPs

General-purpose enterprise LLMs are no longer sufficient in procurement cycles for clinical workflows. Buyers will increasingly demand health-specific models or evidence of fine-tuning on medical corpora. Microsoft's Copilot Health has a distribution and integration advantage wherever Azure, Microsoft 365, and Epic or Oracle EHR installations are standard. OpenAI and Anthropic will rely on channel partners—EHR vendors and digital health platforms—to achieve similar workflow integration. In China, Ant Aofu's 30 million-user base creates a network effect around the Ant and Alipay ecosystem that competitors cannot easily replicate.

The competitive landscape splits along user type and geography. Patient-facing tools—ChatGPT Health, Claude Health, and Ant Aofu—compete on consumer trust, wearables integration, and local market penetration. Clinician-facing tools—ChatGPT for Clinicians and Copilot Health—compete on depth of medical training data, EHR integration, and enterprise licensing terms. Point solutions for clinical decision support, imaging AI, and documentation (from vendors like Aidoc, PathAI, Nuance DAX competitors) must now position against horizontal LLM platforms that are embedding similar capabilities at the infrastructure layer.

What enterprise buyers should do now

Use the Bessemer index to benchmark your AI spend against peer priorities. If your organization is allocating budget to categories that do not appear as high adoption in the 400-buyer sample, prepare to defend those decisions with specific ROI data or strategic rationale. Expect vendors in hot categories to become more aggressive on pricing and contract terms as competition intensifies.

For LLM procurement, define whether you need a patient-facing tool, a clinician-facing tool, or an enterprise platform that integrates with existing EHR and Microsoft infrastructure. Microsoft Copilot Health will be the default option in Azure and Microsoft 365 environments unless you have a specific reason to choose a point solution or a different LLM vendor. OpenAI and Anthropic offerings require evaluation of channel partner integrations and API pricing models compared to Microsoft's bundled enterprise agreements.

If a vendor claims their clinical AI product is differentiated, ask which category in the Bessemer index it maps to and what the adoption rate is in that category. If they cannot answer, the product is either too early or too niche to justify budget in a constrained environment. The market is moving from experimentation to standardization. Buyers who treat clinical AI as a pilot program rather than a platform decision will find themselves behind by mid-2027.